Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Linkedin

<< Previous

Bullboard Posts

Next >>

Post by Trogarzonon Jun 06, 2024 3:45pm

189 Views

Post# 36076102

Another invigorating BIO International Convention for our team, as we actively seek out partners and products to enhance Theratechnologies’ value proposition for our stakeholders and for the many patients with unmet medical needs...

Ok, does this tell us they have a partner now or even close to having one... No

Ok. does this tell us they are in a strong negociation position... No

Ok, is this good messaging from the company... No

<< Previous

Bullboard Posts

Next >>

FLYHT and WestJet partner on weather forecasting